[1] World Health Organization (WHO). Global Tuberculosis Report 2012; WHO Press, World Health Organization: Geneva, Switzerland, 2012.
[2] Zhang, Y.; Post-Martens, K.; Denkin, S. Drug Discov. Today. 2006, 11, 21-27.
[3] Pham, T.; Nguyen, T.; Nguyen, L. J. Anc. Dis. Prev. Rem. 2013, 1, 1-2.
[4] World Health Organization (WHO). The use of bedaquiline in the treatment of multidrug-resistant tuberculosis, Interim Policy Guidance. WHO Press, World Health Organization: Geneva, Switzerland, 2013.
[5] Anishetty, S.; Pulimi, M.; Pennathur, G. Comput. Biol. Chem. 2005, 29, 368-378.
[6] Ahmad, S.; Mokaddas, E. Respiratory. Medicine. CME. 2010, 3, 51-56.
[7] World Health Organization (WHO). Guidelines for the programmatic management of drug-resistant tuberculosis: Emergency Update 2008. WHO Press, World Health Organization: Geneva, Switzerland, 2008.
[8] World Health Organization (WHO). Treatment of Tuberculosis Guidelines.Fourth Edition. WHO Press, World Health Organization: Geneva, Switzerland, 2010.
[9] Orenstein, E.W.; Basu, S.; Shah, S. Lancet. Infect. Dis. 2009, 9, 153-161.
[10] American Thoracic Society, CDC, and Infectious Disease Society of America. Treatment of tuberculosis. MMWR. 2003, 52, 1-77.
[11] Conde, M.B.; Silva, J.R.L. Drug Dev. Res. 2011, 72, 501-508.
[12] Dover, L.G.; Coxon, G.D. J. Med. Chem. 2011, 54, 6157-6165.
[13] Wright, A.; Bai, G.; Barrera, L.; Boulahbal, F.; Martín-Casabona, N.; Gilpin, C.; Drobniewski, F.; Havelkova, M.; Lepe, R.; Lumb, R.; Metchock, B.; Portaels, F.; Rodrigues, M.; Rusch-Gerdes, S.; Van Deun, A.; Vincent, V.; Leimane, V.; Riekstina, V.; Skenders, G.; Holtz, T.; Pratt, R.; Laserson, K.; Wells, C.; Cegielski, P.; Shah, N.S. Morbidity Mortality Wkly Rep. 2006, 55, 301-305.
[14] WHO Global Task Force Outlines Measures to Combat XDRTB Worldwide. http//www.who.int/mediacentre/news/notes/2006 np29/en/index.html
[15] Mario, C.; Raviglione, M.D. N. Engl. J. Med. 2008, 359, 6.
[16] Velayati, A.A.; Masjedi, M.R.; Farnia, P.; Tabarsi, P.; Ghanavi, J.; Ziazarifi, A.H.; Hoffner, S.E. Chest. 2009, 136, 420-425.
[17] Rowland, K. Nature. 2012, 13.
[18] Udwadia, Z.F.; Amale, R.A.; Ajbani, K.K.; Rodrigues, C. Clin. Infect. Dis. 2011, 54, 579-581.
[19] Harries, A.D.; Zachariah, R.; Corbett, E.L. Lancet. 2010, 375, 1906-1919.
[20] Toossi, Z.; Xia, L.; Wu, M.; Salvekar, A. Clin. Exp. Immunol. 1999, 117, 324-330.
[21] Boulle, A.; Van-Cutsem, G.; Cohen, K. J. Am. Med. Assoc. 2008, 300, 530-539.
[22] Manosuthi, W.; Sungkanuparph, S.; Tantanathip, P. Clin. Infect. Dis. 2009, 48, 1752-1759.
[23] L’homme, R.F.; Nijland, H.M.; Gras, L. Aids. 2009, 27, 863-865.
[24] Nijland, H.M.; L’homme, R.F.; Rongen, G.A. Aids. 2008, 22, 931-935.
[25] Blanc, F.X.; Sok, T.; Laureillard, D. N. Engl. J. Med. 2011, 365, 1471-1481.
[26] Karim, S.A.; Naidoo, N.P.; Grobler, A. N. Engl. J. Med. 2011, 365, 1492-1501.
[27] Havlir, D.V.; Kendall, M.A.; Ive, P. N. Engl. J. Med. 2011, 365, 1482-1491.
[28] Leach, K.L.; Brickner, S.J.; Noe, M.C.; Miller, P.F.; Ann, N.Y. Acad. Sci. 2011, 1222, 49-54.
[29] Zhang, Y.; Post-Martens, K.; Denkin, S. Drug. Discov. Today. 2006, 11, 21-27.
[30] Williams, K.N.; Stover, C.K.; Zhu, T.; Tasneen, R.; Tyagi, S.; Grosset, J.H.; Nuermberger, E. Antimicrob. Agents.Chemother. 2009, 1314-1319.
[31] Dietze, R.; Hadad, D.J.; Mc Gee, B. Am. J. Respir. Crit. Care. Med. 2008, 178, 1180-1185.
[32] Khasawneh, F.A.; Moti, D.F.; Zorek, J.A. J. Medical. Case. Reports. 2013, 7, 46.
[33] Jones, D. Nature Rev. 2013, 3, 12.
[34] Williams, K.N.; Stover, C.K.; Zhu, T. Antimicrob. Agents Chemother. 2009, 53, 1314-1319.
[35] Alffenaar, J.W.C.; van-der Laan, T.; Simons, S.; van-der Werf, T.S.; van-de Kasteele, P.J.; de Neeling, H.; Soolingen, D.V. Antimicrob. Agents. Chemother. 2011, 55, 1287-1289.
[36] Wallis, R.S.; Jakubiec, W.M.; Kumar, V.; Silvia, A.M.; Paige, D.; Dimitrova, D.; Li, X.; Ladutko, L.; Campbell, S.; Friedland, M.G.; Miller, P.F. J. Infect. Dis. 2009, 202, 745-751.
[37] Reele, S.; Xiao, A.J.; Das, S. Antimicrob. Agents Chemother. 2011, 17-20.
[38] Xiao, A.J.; Das, S.; Reele, S. Antimicrob. Agents Chemother. 2011, 17-20.
[39] Matsumoto, M.; Hashizume, H.; Tomishige, T. PLoS Med. 2006, 3, 466.
[40] Zhang, Q.; Liu, Y.; Tang, S.; Sha, W.; Xiao, H. Cell Biochem. Biophys. 2013, 67, 957-963.
[41] Choi, K.P.; Bair, T.B.; Bae, Y.M.; Daniels, L. J. Bacteriol. 2001, 183, 7058-7066.
[42] Singh, R.; Manjunatha, U.; Boshoff, H. Science. 2008, 322, 1392-1395.
[43] Manjunatha, U.; Boshoff, H.I.M.; Barry, C.E. Comm. Integr. Biol. 2009, 2, 215-218.
[44] Lenaerts, A.J.; Gruppo, V.; Marietta, K.S.; Johnson, C.M.; Driscoll, D.K.; Tompkins, N.M.; Rose, J.D.; Reynolds, R.C.; Orme, I.M. Antimicrob. Agents. Chemother. 2005, 49, 2294-2301.
[45] Nuermberger, E.; Tyagi, S.; Tasneen, R.; Williams, K.N.; Almeida, D.; Rosenthal, I.; Grosset, J.H. Antimicrob. Agents. Chemother. 2008, 52, 1522-1524.
[46] Richard, H. (National Institute of Allergy and Infectious Diseases, Bethesda, MD). E-mail with: Erica Lessem (Treatment Action Group, New York, NY), June 4, 2012.
[47] Andries, K.; Verhasselt, P.; Guillemont, J. Science. 2005, 307, 223-227.
[48] Lounis, N.; Veziris, N.; Chauffour, A. Antimicrob. Agents. Chemother. 2006, 50, 3543-3547.
[49] Lessem, E.; McKenna, L. An Activist’s Guide to Bedaquiline (Sirturo). Treatment Action Group. February 2013.
[50] Gaurrand, S.; Desjardins, S.; Meyer, C. Biol. Drug. Des. 2006, 68, 77-84.
[51] Mahajan, R. Int. J. App. Basic. Med. Res. 2013, 3, 1-2.
[52] Matteelli, A.; Carvalho, A.C.C.; Dooley, K.E. Future Microbiol. 2010, 5, 849-858.
[53] Rustomjee, R.; Diacon, A.H.; Allen, J. Agents. Chemother. 2008, 52, 2831-2835.
[54] Diacon, A.H.; Pym, A.; Grobudch, M. N. Engl. J. Med. 2009, 360, 2397-2405.
[55] Diacon, A.H.; Donald, P.R.; Pym, A. Agents. Chemother. 2012, 56, 3271-3276.
[56] Okumura, R.; Hirata, T.; Onodera, Y.; Hoshino, K.; Otani, T.; Yamamoto, T. J. Antimicrob. Chemother. 2008, 62, 98-104.
[57] Hoshino, K.; Inoue, K.; Murakami, Y.; Kurosaka, Y.; Namba, K.; Kashimoto, Y.; Uoyama, S.; Okumura, R.; Higuchi, S.; Otani, T. Antimicrob. Agents. Chemother. 2008, 52, 65-76.
[58] Disratthakit, A.; Doi, N. Antimicrob. Agents. Chemother. 2010, 54, 2684-2686.
[59] Ahmad, Z.; Minkowski, A.; Peloquin Williams, K.N.; Mdluli, K.E.; Grosset, J.H.; Nuermberger, E.L. Antimicrob. Agents. Chemother. 2011, 1781-1783.
[60] Hotoda, H.; Furukawa, M.; Daigo, M.; Murayama, K.; Kaneko, M.; Muramatsu, Y.; Ishii, M.M.; Miyakoshi, S.; Takatsu, T.; Inukai, M.; Kakuta, M.; Abe, T.; Harasaki, T.; Fukuoka, T.; Utsui, Y.; Ohya, S. Bioorg. Med. Chem. Lett. 2003, 13, 2829-2832.
[61] Nikonenko, B.V.; Protopopova, M.; Samala, R.; Einck, L.; Nacy, C.A. Antimicrob. Agents. Chemother. 2007, 51, 1563-1565.
[62] Tahlan, K.; Wilson, R.; Kastrinsky, D.B.; Arora, K.; Nair, V.; Fischer, E.; Barnes, S.W.; Walker, J.R.; Alland, D.; Barry, III C.E.; Boshoff, H.I. Antimicrob. Agents. Chemother. 2012, 56, 1797-1809.
[63] Protopopova, M.; Hanrahan, C.; Nikonenko, B.; Samala, R.; Chen, P.; Gearhart, J.; Einck, L.; Nacy, C.A. J. Antimicrob. Chemother. 2005, 56, 968-974.
[64] Kimura, K.I.; Bugg, T.D.H. Nat. Prod. Rep. 2003, 20, 252-273.
[65] Bugg, T.D.; Lloyd, A.J.; Roper, D.I. Infect. Disord. Drug. Targets. 2006, 6, 85-106.
[66] Nikonenko, B.V.; Reddy, V.M.; Protopopova, M.; Bogatcheva, E.; Einck, L.; Nacy, C.A. Antimicrob. Agents. Chemother. 2009, 53, 3138-3139.
[67] Reddy, V.M.; Einck, L.; Nacy, C.A. Antimicrob. Agents. Chemother. 2008, 52, 719-721.
[68] Arora, S. Int. J. Tuberc. Lung. Dis. 2004, 8, S29.
[69] Arora, S.K.; Sinha, N.; Jain, A. Patent WO200426828, 2004.
[70] Arora, S.K.; Sinha, N.; Sinha, R.; Upadhayaya, R.S. Patent US20050256128, 2005.
[71] Cardona, P.J. Rijeka: InTech, 2012, 560.
[72] Lechartier, B.; Hartkoorn, R.C.; Cole, S.T. Antimicrob. Agents. Chemother. 2012, 56, 5790.
[73] Karoli, T.; Becker, B.; Zuegg, J.; Mollmann, U.; Ramu, S.; Huang, J.X.; Cooper, M.A. J. Med. Chem. 2012, 55, 7940-7944.
[74] Batt, S.M.; Jabeen, T.; Bhowruth, V.; Quill, L.; Lund, P.A.; Eggeling, L.; Alderwick, L.J.; Fütterer, K.; Besra, G.S. 2012, 109, 11354-11359.
[75] Makarov, V.; Manina, G.; Mikusova, K. Science. 2009, 324, 801-804.
[76] Brodin, P.; Christophe, T. Curr. Opin. Chem. Biol. 2011, 15, 534-539.
[77] Makarov, V.; Neres, J.; Hartkoorn, R.C.; Ryabova, O.B.; Kazakova, E.; Šarkan, M.; Huszár, S.; Piton, J.; Kolly, G.S.; Vocat, A.; Conroy, T.M.; Mikušová, K.; Cole, S.T. Antimicrob. Agents Chemother. 2015, 9, 4446-4452.
[78] Carette, X.; Blondiaux, N.; Willery, E. Nucl. Acids. Res. 2011, 1-13.
[79] Willand, N.; Dirie, B.; Carette, X.; Bifani, P.; Singhal, A.; Desroses, M.; Leroux, F.; Willery, E.; Mathys, V.; De’prez-Poulain, R.; Delcroix, G.; Frenois, F.; Aumercier, M.; Locht, C.; Villeret, V.; Deprez, B.; Baular, A.R. Nat. Med. 2009, 15, 537-544.
[80] Engohang-Ndong, J.; Baillat, D.; Aumercier, M.; Bellefontaine, F.; Besra, G. S.; Locht, C.; Baulard, A.R. Mol. Micro. Boil. 2004, 51, 175-188.
[81] Bogatcheva, E.; Hanrahan, C.; Nikonenko, B.; de los Santos, G.; Reddy, V.; Chen, P.; Barbosa, F.; Einck, L.; Nacy, C.; Protopopova, M. Bioorg. Med. Chem. Lett. 2011, 21, 5353-5357.
[82] Arora, S. Int. J. Tuberc. Lung. Dis. 2004, 8, S29.
[83] Arora, S.K.; Sinha, N.; Jain, A. Patent WO200426828, 2004.
[84] Arora, S.K.; Sinha, N.; Sinha, R.; Upadhayaya, R.S. Patent US20050256128, 2005.
[85] Cardona, P.J. editor. Rijeka: InTech. 2012, 1-46.
[86] Iseman, M.D. Eur Respir J. 2002, 36, S87-94.
[87] Manika, K.; Kioumis, I. 2008, 21, 395-401.
[88] Gosling, R.D.; Uiso, L.O.; Sam, N.E. Am. J. Respir. Crit. Care. Med. 2003, 168, 1342-1345.
[89] Von Keutz, E.; Schluter, G. J. Antimicrob Chemother. 1999, 43, 91-100.
[90] Johnson, J.L.; Hadad, D.J.; Boom, W.H. Int. J. Tuberc. Lung Dis. 2006, 10, 605-612.
[91] Nuermberger, E.L.; Yoshimatsu, T.; Tyagi, S. Am. J. Respir. Crit. Care. Med. 2004, 169, 421-426.
[92] Burman, W.J.; Goldberg, S.; Johnson, J.L. Am. J. Respir. Crit. Care. Med. 2006, 174, 331-338.
[93] Alvirez-Freites, E.J.; Carter, J.L.; Cynamon. M.H. Antimicrob. Agents. Chemother. 2002, 46, 1022-1025.
[94] Kratky, M.; Vinsova, J. Curr. Med. Chem. 2012, 19, 6126-6137.
[95] Dunn, M.F.; Trujillo, J.A.R.; Hernandez-Lucas, I. Microbiology. 2009, 3166-3175.
[96] Reddy, V.M.; O’Sullivan, J.F.; Gangadharam, P.R.J. J. Antimicrob. Chemother. 1999, 43, 615-623.
[97] Field, S.K.; Cowie, R.L. Chest. 2003, 124, 1482-1786.
[98] Reddy, V.M.; Srinivasan, S.; Gangadharam, P.R. Tuber. Lung. Dis. 1994, 75, 208-212.
[99] Reddy, V.M.; Nadadhur, G.; Daneluzzi, D.; O’Sullivan, J.F.; Gangadharam, P.R. Antimicrob. Agents, Chemother. 1996, 40, 633-636.
[100] Liu, B.; Liu, K.; Lu, Y.; Zhang, D.; Yang, T.; Li, X.; Ma, C.; Zheng, M.; Wang, B.; Zhang, G.; Wang, F.; Ma, Z.; Li, C.; Huang, H.; Yin, D. Molecules. 2012, 17, 4545-4559.
[101] Barry, V.C.; Belten, J.G.; Cnalty, M.L.; Denneny, J.M.; Edward, D.W.; O’Sullivan, J,F. Nature. 1957, 179, 1013-1015.
[102] Morrission, N.E.; Marley, G.M. Int. J. Lepr. 1957, 44, 133-134.
[103] Zhang, D.; Lu, Y.; Liu, K. J. Med. Chem. 2012, 55, 8409−8417.
[104] De Lorenzo, S.; Alffenaar, J.W.; Sotgiu, G. Eur. Respir. J. 2013, 41, 1386-1392.
[105] Alsaad, N.; Wilffert, B.; van Altena, R. Eur. Respir. J. 2014, 43, 884-897.
[106] Alsaad, N.; van Altena, R.; Pranger, A.D. Eur. Respir. J. 2013, 42, 504-512.
[107] Jawahar, M.S.; Banurekha, V.V.; Paramasivan, C.N. PLoS One. 2013, 8, e67030.
[108] Merle, C.S.; Fielding, K.; Sow, O.B. N. Engl. J. Med. 2014, 371, 1588-1598.
[109] Merle, C.S.; Sismanidis, C.; Sow, O.B. Trials. 2012, 13, 61.
[110] Smythe, W.; Merle, C.S.; Rustomjee, R. Antimicrob. Agents. Chemother. 2013, 57, 4164-4171.
[111] Dawson, R.; Diacon, A.H.; Everitt, D. Lancet. 2015, 385, 1738-1747.
[112] Sotgiu, G.; Migliori, G.B. Eur. Respir. J. 2015, 45, 25-29.
[113] Falzon, D.; Jaramillo, E.; Schünemann, H.J. Eur. Respir. J. 2011, 38, 516-528.
[114] World Health Organization.WHO Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2014.11. Geneva, World Health Organization. 2014.
[115] Dara M, Kluge H. Roadmap to prevent and combat drug-resistant tuberculosis. Copenhagen, World Health Organization Regional Office for Europe. 2011. www.euro.who.int/__data/assets/pdf_file/0014/152015/ e95786.pdf
[116] Heysell, S.K.; Moore, J.L.; Keller, S.J. Emerging. Infect. Dis. 2010, 16, 1546-1553.
[117] Peloquin, C.A.; Ann, N.Y. Acad. Sci. 2001, 953, 157-164.
[118] Peloquin, C.A. Drugs. 2002, 62, 2169-2183.
[119] Migliori, G.B.; Sotgiu, G.; D’Ambrosio, L. Eur. Respir. J. 2012, 39, 619-625.
[120] Raviglione, M.C.; Lange, C.; Migliori, G.B. Eur. Respir. J. 2011, 37, 978-981.
[121] Van der Werf, M.J.; Langendam, M.W.; Huitric, E. Eur. Respir. J. 2012, 39, 1511-1519.
[122] Srivastava, S.; Pasipanodya, J.G.; Meek, C. J. Infect. Dis. 2011, 204, 1951-1959.
[123] Sotgiu, G.; Centis, R.; D’Ambrosio, L. Eur. Respir. J. 2012, 40, 1430-1442.
[124] Srivastava, S.; Peloquin, C.A.; Sotgiu, G. Eur. Respir. J. 2013, 42, 1449-1453.
[125] Vu, D.H.; Alffenaar, J.W.C.; Edelbroek, P.M. Curr. Pharm. Des. 2011, 17, 2931-2939.
[126] Migliori, G.B.; Zellweger, J.P.; Abubakar, I. Eur. Respir. J. 2012, 39, 807-819.
[127] van der Werf, M.J.; Sandgren, A.; D’Ambrosio, L. Eur. Respir. J. 2014, 43, 933-942.
[128] World Health Organization.Framework for tuberculosis elimination in low-incidence countries. Document WHO/HTM/TB/2014.13. Geneva, World Health Organization. 2014.
[129] Diel, R.; Loddenkemper, R.; Zellweger, J.P. Eur. Respir. J. 2013, 42, 785-801.
[130] D’Ambrosio, L.; Dara, M.; Tadolini, M. Eur. Respir. J. 2014, 43, 1410-1420.
[131] Voniatis, C.; Migliori, G.B.; Voniatis, M. Eur. Respir. J. 2014, 44, 543-546.
[132] Blasi, F.; Barnes, P.J.; Gaga, M. Eur. Respir. J. 2013, 42, 875-880.
[133] Blasi, F.; Reichman, L.B.; Migliori, G.B. Eur. Respir. J. 2012, 40, 806-808.
[134] Esposito, S.; D’Ambrosio, L.; Tadolini, M. Eur. Respir. J. 2014, 44, 811-815.
[135] Codecasa, L.R.; Ciconali, G.; Mazzola, E. Eur. Respir. J. 2015, 45, 25-29.
[136] D’Ambrosio, L.; Tadolini, M.; Dupasquier, S. Eur. Respir. J. 2014, 43, 286-289.
[137] Janssen, S.; Jayachandran, R.; Khathi, L. Drug Design, Development & Therapy. 2012, 6, 217-224.
[138] Kinnings, S.L.; Liu, N.; Buchmeier, N. PLoSComput Biol. 2009, 5, 1-10.
[139] Mor, A. Drug. Dev. Res. 2000, 50, 440-447.
[140] McDermott, W. Yale. J. Biol. Med. 1958, 30, 257-291.
[141] McKinney, J.D.; HönerzuBentrup, K.; Muñoz-Elías, E.J. Nature. 2000, 406, 735-738.
[142] Glickman, M.S.; Cox, J.S.; Jacobs, W.R. Mol. Cell. 2000, 5, 717-727.
[143] Dahl, J.L.; Kraus, C.N.; Boshoff, H.I.M. Proc. Natl. Acad. Sci. 2003, 100, 10026-10031.
[144] Park, H.D.; Guinn, K.M.; Harrell, M.I. Mol. Microbiol. 2003, 48, 833-843.
[145] Zhang, Y.; Wade, M.M.; Scorpio, A. J. Antimicrob. Chemother. 2003, 52, 790-795.
[146] Engelberg-Kulka, H.; Sat, B.; Reches, M. Trends Microbiol. 2004, 12,66-71.
[147] Gerdes, K.; Christensen, S.K.; Løbner-Olesen, A. Nat. Rev. Microbiol. 2005, 3, 371-382.
[148] Sassetti, C.M.; Boyd, D.H.; Rubin, E.J. Mol. Microbiol. 2003, 48, 77-84.
[149] Sassetti, C.M.; Rubin, E. J. Proc. Natl. Acad. Sci. USA. 2003, 100, 12989-12994.
[150] Ollinger, J.; O'Malley, T.; Kesicki, E.A. J. Bacteriol. 2012, 194, 663-668.
[151] Sacks, L.V.; Behrman, R.E. Tuberculosis. 2008, 88, S93-S100.
[152] Casenghi, M.; Cole, S.T.; Nathan, C.F. PLoS Med, 2007, 4, 1722-1725.
[153] Boogaard, J.; Kibiki, G.S.; Kisanga, E.R. Antimicrob. Agents. Chemother. 2009, 53, 849-862.
[154] Zhang, Y. Front. Biosci. 2004, 9, 1136-1156.
[155] Tomioka, H.; Namba, K. Kekkaku. 2006, 81, 753-774.
[156] Ginsberg, A.M.; Spigelman, M. Nature Medicine. 2007, 13, 290-294.
[157] Pandey, R.; Khuller, G.K. J. Antimicrob. Chemother. 2004, 54, 266-268.
[158] Gelperina, S.; Kisich, K.; Iseman, M.D. Am. J. Respir. Crit. Care. Med. 2005, 172, 1487-1490.
[159] Pandey, R.; Zahoor, A.; Sharma, S. Tuberculosis. 2003, 83, 373-378.
[160] Nuermberger, E.L.; Spigelman, M.K.; Yew, W.W. Respirology. 2010, 15, 764-778.
[161] Anisimova, Y.V.; Gelperina, S.; Peloquin, C. J. Nanoparticle. Res. 2000, 2, 165-171.
[162] Barrow, E.L.; Winchester, G.A.; Staas, J.K. Antimicrob. Agents Chemother. 1998, 42, 2682-2689.
[163] Fawaz, F.; Bonini, F.; Maugein, J. Int. J. Pharm, 1998, 168, 255-259.
[164] Grosset, J. Antimicrob. Agents. Chemother. 2003, 47, 833-836.
[165] Pandey, R.; Khuller, G.K. J. Antimicrob. Chemother. 2005, 55, 430-435.
[166] Fiegel, J.; Garcia-Contreras, L.; Thomas, M. Pharm. Res. 2008, 25, 805-811.
[167] Garcia-Contreras, L.; Sung, J.C.; Muttil, P. Antimicrob. Agents. Chemother. 2010, 54, 1436-1442.
[168] Garcia-Contreras, L.; Fiegel, J.; Telko, M.J. Antimicrob. Agents. Chemother. 2007, 51, 2830-2836.
[169] Asif, M. Orien.Pharm. Experi. Med. 2012, 12, 15-34.
[170] Asif, M. Indian. Drugs. 2012, 49, 5-19.
[171] Asif, M. Mini. Rev. Med. Chem. 2012, 12, 1404-1418.
[172] Asif, M.; Siddiqui, A.A.; Husain, A. Med. Chem. Res. 2013, 22, 1029-1042.
[173] Asif, M. Org. Chem: An Indian J. 2013, 9, 180-218.
[174] Lienhardt, C.; Raviglione, M.; Spigelman, M. J. Infect. Dis. 2012, 205, S241-S249.
[175] Lienhardt, C.; Vernon, A.; Raviglione, M.C. Curr. Opinion Pulmonary Med. 2010, 16, 186-193.
[176] Yadav, P.; Deolekar, P.; Kanase, V. IJPSR. 2012, 3, 2472-2481.
[177] Shehzad, A.; Rehman, G.; Ul-Islam, M. Braz. J. Infect. Dis. 2013, 17, 74-81.
[178] Anand, N.; Upadhyaya, K.; Tripathi, R.P. Chem.& Biol. Interface. 2015, 5, 84-127.
[179] Godebo, A.; Woldi, A.H.; Toma, A. Inter. J. Res. Pharm. Biosci. 2015, 2, 1-18.
[180] Kurbatova, E.V.; Cegielski, J.P.; Lienhardt, C. Lancet. Respir. Med. 2015, 3, 201-209.
[181] Zumla, A.I.; Schito, M.; Maeurer, M. Lancet. Infect. Dis. 2014, 14, 7-9.
[182] D’Ambrosio, L.; Centis, R.; Sotgiu, G.; Pontali, E.; Spanevello, A.; Migliori, G.B. ERJ. Open. Res. 2015, 1, 182. |